Market Share of Global Postmenopausal Osteoporosis Industry
The postmenopausal osteoporosis market is fragmented and competitive due to several generics in the market. However, some of the key players operating in the market are Novartis International AG, Eli Lilly and CO., Pfizer Inc., Merck & Co., Inc., BiologicsMD, AbbVie (Allergan plc.), and Cipla Inc. Increasing awareness about postmenopausal osteoporosis, developing new drugs, and partnerships or collaborations to reach their drugs at maximum patients are some strategies market players are utilizing to gain market share in the industry.
Postmenopausal Osteoporosis Market Leaders
Amgen Inc.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
Allergan plc
*Disclaimer: Major Players sorted in no particular order
